Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Background and Objective: Dual antiplatelet therapy (DAPT) is the basis for preventing ischemic events after percutaneous coronary intervention (PCI), and DAPT for 12 months has been the standard strategy recommended by the guidelines. However, patients with acute coronary syndrome (ACS) have a high...

Descrición completa

Detalles Bibliográficos

Principais autores:	Peng-Yu Zhong, Yao-Sheng Shang, Nan Bai, Ying Ma, Ying Niu, Zhi-Lu Wang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Cardiovascular Medicine
Assuntos:	acute coronary syndrome percutaneous coronary intervention drug-eluting stents dual antiplatelet therapy trial sequential analysis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.660360/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!